Menu
Log in
  • Home
  • IDAC 36th Annual Fall Symposium

IDAC 36th Annual Fall Symposium

  • November 06, 2021
  • 7:30 AM - 5:00 PM
  • Long Beach Marriott, 4700 Airport Plaza Drive, Long Beach

Registration


Registration is closed

Orthopedic Hardware Joint Infections: Carlos A. Higuera-Rueda, MD, FAAOS, Amy and David Krohn Family Distinguished Chair in Orthopaedic Outcomes, Center Director Orthopaedic and Rheumatology, Department Chairman, Levitetz Department of Orthopaedic Surgery, Cleveland Clinic Florida

The Clinical Utility of Whole Genome Sequencing: From SARS CoV-2 to Mycobacterium abscessus : Omai Garner, PhD, UCLA Path & Lab Med,  Associate Professor, Pathology and Laboratory Medicine

Therapeutic Monitoring Beta-lacatam abx Therapy: David P. Nicolau PharmD, FCCP, FIDSA, Director, Center for Anti-Infective Research & Development

Epidemiology, Diagnosis and Treatment of Invasive Fungal Disease complicating COVID-19: Martin Hoenigl, MD, FECMM, Associate Professor of Medicine, Division of Infectious Diseases and Global Public Health, UCSD, Head of the Clinical and Translation Fungal Research UCSD Working Group

Combination Treatment for Staphylococcal Bacteremia: George Sakoulas, MD, Adjunct Professor of Pediatrics at the University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics

Interesting Local Cases: Panel, Arash Heidari, MD, Moderator

Fall 2021 Meeting R3.pdf


ACCREDITATION--
The Infectious Disease Association of California (IDAC) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. IDAC takes responsibility for the content, quality, and scientific integrity of this CME activity.

PHYSICIANS: IDAC designates this educational activity for a maximum of 6.0* AMA PRA Category 1 Credit(s)™ and American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program points for medical knowledge. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

PHARMACISTS: The California Board of Pharmacy accepts coursework which meets the standard of relevance to pharmacy practice and has been approved for AMA PRA Category 1 Credit™. A maximum of 6.0* C.E.U.s may be reported.

NURSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1. Credits™. A maximum of 6.0* C.E.U.s may be reported. .



Powered by Wild Apricot Membership Software